IDEA Pharma announces Founder Mike Rea’s departure after 25 years of transformative leadership

Friday, February 13th, London, England – IDEA Pharma today announces that its Founder and former CEO, Mike Rea, has stepped away from the organisation after 25 years of visionary leadership, bold thinking, and unparalleled contribution to the life sciences industry.

Mike, who founded IDEA Pharma in 1999, shared a personal message on LinkedIn reflecting on his final day with the company and expressing deep gratitude to the colleagues, clients, and partners who have shaped IDEA’s journey. In his message, he wrote that IDEA represented “the best possible years” of his career and that he would remain the company’s “biggest fan.”

During his tenure, Mike built IDEA Pharma into one of the most respected strategy and path‑to‑market consultancies in the industry. His leadership helped pioneer multiple category-defining products and supported some of the world’s most significant pharmaceutical launches. His belief that “pharma can be better” remains a guiding principle for the company.

“Mike’s impact on IDEA, and on the industry, is immeasurable,” said Erik Nordhoy, CEO of SAI. “He built a company rooted in curiosity, courage, and the determination to improve how medicines reach patients. His influence will always be part of IDEA’s DNA, and we are deeply grateful for everything he created.”

While IDEA celebrates Mike’s legacy, the company also affirmed its strong forward momentum. With an established leadership team, deep scientific, clinical, regulatory, and commercial expertise, and a well-proven suite of strategic positioning and path‑to‑market offerings, IDEA remains well-positioned for sustained growth.

“Our team today is the strongest it has ever been, and our client base continues to expand globally, including significant momentum among innovative China biotech companies”, added Jacqueline Poot, President, Strategic Consulting & Analytics of IDEA Pharma. “As we enter this next chapter, we remain committed to client partnerships to turn scientific breakthroughs into commercial success stories in the same spirit that Mike instilled from day one.”

Ends

About IDEA Pharma and SAI

IDEA Pharma, a division of SAI, is a global strategic consultancy practice, recognized as the leading experts in pharmaceutical innovation, path-to-market strategy, and decision intelligence. IDEA Pharma provides deep clinical and commercial expertise to Pharma and Biotech clients, with SAI capabilities in market research, competitor intelligence, benchmarking and market access and pricing. SAI has a global presence with offices in Europe, the United States and Asia.

To learn more, please visit, https://www.sai-med.com/, https://www.ideapharma.com or follow us on LinkedIn, and YouTube

Contact:

For all media enquires please contact:

Jacqueline Poot: Jacqueline.poot@ideapharma.com

Email: info@ideapharma.com